University of Colorado Cancer Center
Playback speed
10 seconds
Brain Mets & CNS Coverage of MET Signaling in NSCLC: Alectinib vs. Crizotinib, Unmet Need in ROS1, TKI Resistance
By
University of Colorado Cancer Center
FEATURING
Tejas Patil
By
University of Colorado Cancer Center
FEATURING
Tejas Patil
0 views
June 11, 2021
Comments 0
Login to view comments.
Click here to Login
Oncology Grand Rounds